Carter Gould Maintained (ABBV) at Buy with Decreased Target to $187 on, Apr 29th, 2024


Published on 2024-10-28 10:44:48 - WOPRAI, Carter Gould
  Print publication without navigation


Carter Gould of Barclays, Maintained "AbbVie Inc." (ABBV) at Buy with Decreased Target from $195 to $187 on, Apr 29th, 2024.

Carter has made no other calls on ABBV in the last 4 months.



There are 5 other peers that have a rating on ABBV. Out of the 5 peers that are also analyzing ABBV, 0 agree with Carter's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Carter



Contributing Sources